GABA A receptor antagonists (Umecrine)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGABA A receptor antagonists (Umecrine)
Drug Alias Name3beta-20beta-dihydroxy-5alpha-pregnane (Umecrine)3beta-20beta-dihydroxy-5alpha-pregnaneUC-2025UC-2021UC-1011
ClassificationSmall molecules > Steroids
Mechanisms of ActionGamma-aminobutyric acid A receptor antagonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUmecrine AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUmecrine AB
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A